176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.05%
Revenue growth at 50-75% of AMD's 20.86%. Martin Whitman would worry about competitiveness or product relevance.
19.02%
Gross profit growth at 50-75% of AMD's 26.83%. Martin Whitman would question if cost structure or brand is lagging.
656.99%
EBIT growth 50-75% of AMD's 1204.02%. Martin Whitman would suspect suboptimal resource allocation.
656.99%
Operating income growth at 50-75% of AMD's 1204.02%. Martin Whitman would doubt the firm’s ability to compete efficiently.
405.55%
Net income growth at 50-75% of AMD's 571.44%. Martin Whitman would question fundamental disadvantages in expenses or demand.
333.33%
EPS growth at 50-75% of AMD's 533.33%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
333.33%
Diluted EPS growth at 50-75% of AMD's 500.00%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.13%
Share reduction while AMD is at 0.91%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.61%
Reduced diluted shares while AMD is at 9.35%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
101.50%
OCF growth above 1.5x AMD's 61.82%. David Dodd would confirm a clear edge in underlying cash generation.
70.07%
FCF growth under 50% of AMD's 275.29%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
276.85%
10Y revenue/share CAGR above 1.5x AMD's 38.74%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
276.85%
Positive 5Y CAGR while AMD is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
20.73%
3Y revenue/share CAGR under 50% of AMD's 157.39%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-97.07%
Negative 10Y OCF/share CAGR while AMD stands at 111.92%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-97.07%
Negative 5Y OCF/share CAGR while AMD is at 16.82%. Joel Greenblatt would question the firm’s operational model or cost structure.
-98.07%
Negative 3Y OCF/share CAGR while AMD stands at 493.74%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
73.09%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
73.09%
Positive 5Y CAGR while AMD is negative. John Neff might view this as a strong mid-term relative advantage.
-49.77%
Negative 3Y CAGR while AMD is 125.69%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
698.62%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
698.62%
Positive 5Y equity/share CAGR while AMD is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
57.36%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.76%
AR growth well above AMD's 17.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.45%
Inventory growth well above AMD's 2.26%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.97%
Asset growth at 75-90% of AMD's 4.98%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
1.34%
75-90% of AMD's 1.77%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-33.27%
We’re deleveraging while AMD stands at 5.97%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
2.88%
R&D dropping or stable vs. AMD's 6.03%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.51%
We cut SG&A while AMD invests at 13.23%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.